Phathom Pharmaceuticals, Inc. (PHAT) Tops Q1 EPS by 9c

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q1 EPS of ($1.11), $0.09 better than the analyst estimate of ($1.20). Revenue for the quarter came in at $1.91 million versus the consensus estimate of $1.89 million.

For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery